Showing results (31-40 of 135) with videos related to
Sort By:
Pageof 14
Journal of Biopharmaceutical Statistics|October 31, 2017
Quantitative assessment of a prognostic or predictive biomarker panelEdward L Korn, Boris FreidlinStatistics in Medicine|February 12, 2005
Testing treatment effects in the presence of competing risksBoris Freidlin, Edward L KornClinical Trials (London, England)|January 7, 2022
Time trends with response-adaptive randomization: The inevitability of inefficiencyEdward L Korn, Boris FreidlinStatistics in Medicine|February 16, 2006
Conditional power calculations for clinical trials with historical controlsEdward L Korn, Boris FreidlinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Monitoring for lack of benefit: a critical component of a randomized clinical trialBoris Freidlin, Edward L KornClinical Trials (London, England)|April 4, 2009
Stopping clinical trials early for benefit: impact on estimationBoris Freidlin, Edward L KornJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2018
Interim Futility Monitoring Assessing Immune Therapies With a Potentially Delayed Treatment EffectEdward L Korn, Boris FreidlinBiometrics|September 29, 2007
A note on controlling the number of false positivesEdward L Korn, Boris FreidlinNature Reviews. Clinical Oncology|November 28, 2013
Biomarker enrichment strategies: matching trial design to biomarker credentialsBoris Freidlin, Edward L KornClinical Trials (London, England)|August 11, 2017
Sample size adjustment designs with time-to-event outcomes: A cautionBoris Freidlin, Edward L KornPageof 14